REFERENCES
- Abelson M B, George M A, Garofalo C. Differential diagnosis of ocular allergic disorders. Ann Allergy. 1993; 70: 95–109, [PUBMED], [INFOTRIEVE], [CSA]
- Allansmith M R, Ross R N. Ocular allergy. Clin Allergy. 1988; 18: 1–13, [PUBMED], [INFOTRIEVE]
- Weeke E R. Epidemiology of hay fever and perennial allergic rhinitis. Monogr Allergy. 1987; 21: 1–20, [PUBMED], [INFOTRIEVE]
- Khosravi E, Elena P P, Hariton C. Allergic conjunctivitis and uveitis models: reappraisal with some marketed drugs. Inflamm Res. 1995; 44: 47–54, [PUBMED], [INFOTRIEVE], [CSA]
- Bielory L. Therapeutic targets in allergic eye disease. Allergy Asthma Proc. 2001; 22: 25–28, [PUBMED], [INFOTRIEVE], [CSA]
- Sharif N A, Xu S X, Miller S T, Gamache D A, Yanni J M. Characterization of the ocular antiallergic and antihistaminic effects of olopatadine (AL-4943A), a novel drug for treating ocular allergic diseases. J Pharmacol Exp Ther. 1996; 278: 1252–1261, [PUBMED], [INFOTRIEVE], [CSA]
- Cook E B, Stahl J L, Barney N P, Graziano F M. Olopatadine inhibits anti-immunoglobin E-stimulated conjunctival mast cell upregulation of ICAM-1 expression on conjunctival epithelial cells. Ann Allergy Asthma Immunol. 2001; 87: 424–429, [PUBMED], [INFOTRIEVE], [CSA]
- Miki I, Kusano A, Ohta S, Hanai N, Otoshi M, Masaki S. Histamine enhanced the TNF-α -induced expression of E-selectin and ICAM-1 on vascular endothelial cells. Cell Immunol. 1996; 171: 285–288, [PUBMED], [INFOTRIEVE], [CSA]
- Cook E B, Stahl J L, Barney N P, Graziano F M. Olopatadine inhibits TNF alpha release from human conjunctival mast cells. Ann Allergy Asthma Immunol. 2000; 84: 504–508, [PUBMED], [INFOTRIEVE], [CSA]
- Schedel I, Ballmaier M, Rohde F, Suttmann U, Deicher H. Ketotifen inhibits tumor necrosis factor alpha production in the peripheral blood mononuclear cells of patients infected with human immunodeficiency virus. J Interferon Res. 1994; 14: 291–292, [PUBMED], [INFOTRIEVE], [CSA]
- Grant S M, Goa K L, Fitton A, Sorkin E M. Ketotifen. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma and allergic disorders. Drugs. 1990; 40: 412–448, [PUBMED], [INFOTRIEVE]
- Woerly G, Loiseau S, Loyens M, Schoch C, Capron M. Inhibitory effects of ketotifen on eotaxin-dependent activation of eosinophils: consequences for allergic eye diseases. Allergy. 2003; 58: 397–406, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Calonge M, Montero J A, Herreras J M, Ramon J J, Pastor J C. Efficacy of nedocromil sodium and cromolyn sodium in an experimental model of ocular allergy. Ann Allergy Asthma Immunol. 1996; 77: 124–130, [PUBMED], [INFOTRIEVE], [CSA]
- Calonge M C, Pastor J C, Herreras J M, Gonzalez J L. Pharmacologic modulation of vascular permeability in ocular allergy in the rat. Invest Ophthalmol Visual Sci. 1990; 31: 176–180
- Woodward D F, Ledgard S E, Nieves A L. Conjunctival immediate hypersensitivity: re-evaluation of histamine involvement in the vasopermeability response. Invest Ophthalmol Visual Sci. 1986; 27: 57–63
- Allansmith M R, Baird R S, Ross R N, Barney N P, Bloch K J. Ocular anaphylaxis induced in the rat by topical application of compound 48/80. Dose response and time course study. Acta Ophthalmol. 1989; 192: 145–153, (Suppl)